Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F46QL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,840
Award facts
- Contract value 100% obligated
- $21,840.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,840.48 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) injectable medication. This competitively awarded, firm fixed-price contract was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contracts covering a broad spectrum of pharmaceutical products and medical supplies across multiple therapeutic domains. As a primary vendor under the DLA's pharmaceutical supply chain, AmerisourceBergen demonstrates consistent capability to meet federal procurement requirements through open competition, with no set-aside designation applied to this award.
Quick answers
Who was awarded contract SPE2DR26F46QL?
SPE2DR26F46QL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F46QL worth?
The government has obligated $21,840 on SPE2DR26F46QL.
Is contract SPE2DR26F46QL an order under another contract?
Yes. SPE2DR26F46QL is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46QL competed?
The extent of competition for SPE2DR26F46QL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award